Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 327
Selected: 0
NCT IDTitle
NCT03601819Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders
NCT00005598Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
NCT05867667Cardiac Rehabilitation to Improve Breast Cancer Outcomes
NCT00580983Optimized Intensity Modulated Irradiation for Head and Neck Cancer
NCT00176748Treatment for Patients With Metastatic Thyroid Cancer
NCT00959998Acupressure for Post-Treatment Cancer Fatigue
NCT00639717Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
NCT03556904FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
NCT00982995Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients
NCT03235869Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma
NCT00116961Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
NCT01661062A Study Using Cone Beam CT for Head and Neck Cancer
NCT02097732Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
NCT00637390A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.
NCT00141765Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
NCT05169957Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)
NCT00645593Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
NCT02338115Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients
NCT04431635Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma
NCT00148135Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
NCT02485470Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy
NCT04272645Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer
NCT01661088A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients
NCT01912612Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain
NCT02973711A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
NCT04480541A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients
NCT02729194Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
NCT01975597Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
NCT03240016Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer
NCT02460835A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma
NCT03639935Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
NCT05988918Multicenter Trial of ESK981 in Patients With Select Solid Tumors
NCT04845035Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NCT00967824Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer
NCT03618017The ConnectedCancerCare Pilot Study (CCC)
NCT02677948Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
NCT02400190The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
NCT05911269Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors
NCT03781986APG-115 in Salivary Gland Cancer Trial
NCT04748042Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
NCT02145403Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
NCT01073436Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha
NCT03287063Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
NCT03559049Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer
NCT02946008Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer
NCT02138578Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma
NCT00615589Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen
NCT06915168CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
NCT00858585Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
NCT02331368Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma